Population Screening Market Share, Size, Trends, Industry Analysis Report, By geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032

Population Screening Market Share, Size, Trends, Industry Analysis Report, By geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032

The global population screening market size is expected treach USD 43.91 billion by 2032, according ta new study by Polaris Market Research. The report “Population Screening Market Share, Size, Trends, Industry Analysis Report, By Geography (Nation, State); By Product; By Application; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

Rising awareness about disease detection and treatment will be a significant factor influencing the growth of the health screening market. In addition, increasing urbanization and disposable income are driving factors accelerating the development of the health screening market. Furthermore, rising healthcare infrastructure spending and people's ever-changing lifestyles are major market drivers that will propel the health screening market forward.

Increasing emphasis on preventive healthcare, the launch of technologically advanced products, growing research and development activities, rising per capita income leading timproving the standard of living, and increasing awareness about the advantages of a healthy lifestyle are expected tpropel the market growth during the forecast period. Thus, the government takes the initiative, which drives the market. For instance, The Maharashtra state government announced a health check-up campaign in October 2022 as a preventive measure for women's safety in the state. Various health-related tests will be performed as part of this campaign tcomplete 30 million women's health tests.

The growing volume and availability of healthcare data and the increasing need tprovide quality care tpatients will force healthcare organizations trely on these new methodologies. This will be used as a strategic competency tdistinguish themselves from competitors and capitalize on growth opportunities.

The nation's population screening market is anticipated tbenefit from the COVID-19 pandemic. For instance, Hayatt Med-Tech startup created the fully automated Hayatt Thermox-D in June 2021 tperform quick COVID-19 testing. With self-disinfection after each session, this device can screen multiple parameters and detect acute symptoms in 12 seconds. Thus, introducing new analytical technologies is expected tboost market expansion.

Population Screening Market Report Highlights

Nation segment is anticipated tgrow over the forecast period because of the effectiveness and precision offered by CTCs in cancer detection

The hardware equipment segment held a dominant share of the market in 2022 Because of the acceptance of new test kits and tools for expanding population screening of more diseases

The hospital segment will generate the most revenue in 2022 owing tthe rising prevalence of chronic diseases, the availability of multiple testing options, and the introduction of new tests for better and more effective patient screening.

North America will dominate the population screening market in 2022, owing tpreventive measures implemented by governments thalt disease progression.

The global players include Agilent Technologies, ThermFisher Scientific, QIAGEN, Roche Ltd., Quest Diagnostics, and Illumina

Polaris Market Research has segmented the population screening market report based on geography, product, application, and region:

Population screening, Geography Outlook (Revenue - USD Billion, 2019 - 2032)

Nation

State

Population screening, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Hardware Equipment

Testing / Lab

Analytics / Interpretation

Population screening, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals

Research Institutes

Diagnostic Labs

Population screening, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa
Show more